Chimerix Inc (CMRX)
1.005
+0.05
(+5.47%)
USD |
NASDAQ |
May 06, 16:00
1.00
0.00 (0.00%)
Pre-Market: 20:00
Chimerix Total Long Term Debt (Quarterly)
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.125M |
September 30, 2023 | 0.125M |
June 30, 2023 | 0.125M |
March 31, 2023 | 0.125M |
December 31, 2022 | 0.25M |
September 30, 2022 | 0.25M |
June 30, 2022 | 0.25M |
March 31, 2022 | 0.25M |
December 31, 2021 | 14.00M |
September 30, 2021 | 14.00M |
June 30, 2021 | 14.00M |
March 31, 2021 | 14.00M |
December 31, 2020 | 0.00 |
September 30, 2020 | 0.00 |
June 30, 2020 | 0.00 |
March 31, 2020 | 0.00 |
December 31, 2019 | 0.00 |
September 30, 2019 | 0.00 |
June 30, 2019 | 0.00 |
March 31, 2019 | 0.00 |
December 31, 2018 | 0.00 |
September 30, 2018 | 0.00 |
June 30, 2018 | 0.00 |
March 31, 2018 | 0.00 |
Date | Value |
---|---|
December 31, 2017 | 0.00 |
September 30, 2017 | 0.00 |
June 30, 2017 | 0.00 |
March 31, 2017 | 0.00 |
December 31, 2016 | 0.00 |
September 30, 2016 | 0.00 |
June 30, 2016 | 0.00 |
March 31, 2016 | 0.00 |
December 31, 2015 | 0.00 |
September 30, 2015 | 0.375M |
June 30, 2015 | 1.484M |
March 31, 2015 | 2.892M |
December 31, 2014 | 4.296M |
September 30, 2014 | 5.695M |
June 30, 2014 | 7.09M |
March 31, 2014 | 8.479M |
December 31, 2013 | 9.867M |
September 30, 2013 | 11.31M |
June 30, 2013 | 12.70M |
March 31, 2013 | 14.00M |
December 31, 2012 | 14.62M |
September 30, 2012 | 0.00 |
June 30, 2012 | 0.00 |
March 31, 2012 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Jun 2019
14.00M
Maximum
Mar 2021
3.026M
Average
0.125M
Median
Mar 2023
Total Long Term Debt (Quarterly) Benchmarks
UFP Technologies Inc | 34.00M |
Dentsply Sirona Inc | 2.09B |
Arbutus Biopharma Corp | 0.00 |
Pacira BioSciences Inc | 522.44M |
Karyopharm Therapeutics Inc | 170.92M |